Eam Investors, LLC Acadia Pharmaceuticals Inc Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $1.4 Million - $2.2 Million	-38,555 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $1.51 Million - $2.03 Million	38,555 New	38,555 $1.87 Million
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $1.58 Million - $2.34 Million	-49,891 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$36.21 - $51.4 $84,333 - $119,710	2,329 Added 4.9%	49,891 $2.13 Million
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $1.06 Million - $2.09 Million	47,562 New	47,562 $1.71 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.73B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.